Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade
Douglas C. Palmer(AstraZeneca (Japan)), Nicholas P. Restifo(Lyell Immunopharma (United States))
Cited by 15
Related Papers
Identification of essential genes for cancer immunotherapy
|Nature|2017|890
IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy
|Blood|2008|459
Increased intensity lymphodepletion and adoptive immunotherapy—how far can we go?
|Nature Clinical Practice Oncology|2006|348
BACH2 regulates CD8+ T cell differentiation by controlling access of AP-1 factors to enhancers
|Nature Immunology|2016|329